Opinion | The biotech and pharma industries are pouring billions of dollars into AI-driven drug discovery and development. But the genomic data used to train AI models are often incomplete, contain errors, or lack contex
Related stories
Podcast: Should We Put AI-Enabled Tech in Our Brains?
Engineering Animals to Grow Human Organs — But Not Human Minds
AI Presents Science with a ‘Ship of Theseus’ Problem
Ask Ethan: If intelligent alien life exists, will we make contact?
The philosophy of liberalism and how it has transformed our institutions
Gentle Exercise May be More Effective Than Medications at Managing Chronic Pain